Genetic Test Improves Celiac Disease Risk Prediction

A new four-tier classification system offers better accuracy in identifying high-risk individuals for celiac disease.

Updated on Oct. 15, 2026 in Nutrition

A detailed, translucent molecular protein structure with metallic links against a clean, out-of-focus laboratory background. — Researchers at the Wisevoter study have introduced a four-tier genetic risk system that enhances prediction accuracy for celiac disease in families. AI Illustration. Upload story photo >

Live Poll

Would you prefer genetic testing to determine the frequency of your personal medical screenings?

Researchers have developed a four-tier genetic risk classification that outperforms binary screening for identifying celiac disease. The study utilized whole-exome sequencing to categorize risk among first-degree relatives of patients.

Why it matters

Refined genetic risk assessments could enable more frequent monitoring for those most likely to develop the disease while reducing unnecessary diagnostic testing for those at low risk. This approach aims to personalize care for families affected by the condition.

The study analyzed 224 individuals from 66 families, with 10% of participants classified as high risk and 50% as negligible risk. Researchers assessed HLA genotypes and risk haplotypes to achieve a classification accuracy of 0.72.

The players

American College of Gastroenterology

This is a professional medical organization that promotes the study and clinical practice of gastroenterology in the United States.

The details

By applying a four-tier classification system to data from 107 patients and 117 unaffected relatives, scientists achieved greater predictive precision than standard binary models. The findings indicate that while all patients carried recognized HLA-DQ risk haplotypes, 15% of unaffected relatives carried none of the assessed markers.

October 15, 2026: The research findings were presented at the Annual Meeting of the American College of Gastroenterology.

Health Landscape

This study advances the current clinical understanding of the human leukocyte antigen (HLA) system in celiac disease screening by providing a more granular classification method for family-based risk. It represents a significant update to existing binary models that have historically relied on single-marker HLA-DQ assessment.

This research provides a roadmap for potentially more precise genetic screening, which could eventually limit the need for frequent invasive testing for family members. Future clinical applications may lead to earlier identification and personalized monitoring protocols for those at high risk.

The takeaway

Future efforts to improve risk prediction may incorporate additional methods such as immunophenotyping and RNA-sequence data. These advanced approaches are intended to complement current genetic tools to provide a more complete picture of celiac disease risk.